Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_assertion description "[Epigenetic inactivation of Plk2 via aberrant CpG methylation in the transcriptional regulatory elements of the gene is a common event in B cell neoplasia, whereas epigenetic inactivation of Plk3 is exceedingly rare in lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_assertion evidence source_evidence_literature NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_assertion SIO_000772 16868416 NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_assertion wasDerivedFrom befree-2016 NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_assertion wasGeneratedBy ECO_0000203 NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.
- befree-2016 importedOn "2016-02-19" NP561421.RA4t-JSkJ7a3P8bOztAv60NhR4TaW7n6ALonCTVynDW-Q130_provenance.